Skip to main content
. 2016 Oct 13;49(4):532–538. doi: 10.1111/evj.12629

Figure 2.

Figure 2

Logarithmically transformed a) mean total nucleated cell counts and b) mean total protein in synovial fluid in the different treatment groups (green: meloxicam; blue: supplement AT; yellow: supplement HP; red: placebo) over time (post‐injection days [PID] −61, 0, 0.3, 1 and 2). Within time points, outcomes in treatments with different superscripts show statistically significant differences.